Delivery Order SPE2DB22D3102-SPE2DB24FK9NU
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $61,256 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply MENQUADFI VIAL 0.5ML pharmaceutical products. This delivery order was placed under Amerisourcebergen's existing indefinite delivery contract with DLA Troop Support Medical to provide pharmaceuticals and medical supplies for military treatment programs and facilities. The contract has a completion date of...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply MENQUADFI VIAL 0.5ML pharmaceuticals. The $1,053.72 contract has a completion date of December 21, 2023. Amerisourcebergen Drug Corp, as a prime contractor, has a history of providing a range of pharmaceutical products and medical supplies to support DLA programs. No set-aside designation was used for this...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $143,356.00 firm fixed price delivery order is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. The contract performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order was not...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $1,756.20 order is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. The award does not have a set-aside designation and the place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is an experienced...
- This is a firm fixed price delivery order worth $108,374.22, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The order is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. No set-aside designation was used. AmerisourceBergen Drug Corp is a prime contractor that has received numerous federal contracts from DLA Troop Support Medical to provide...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,107.44 firm fixed price delivery order is for the provision of MENQUADFI VIAL 0.5ML pharmaceutical products. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical worth $1,391.76 to supply 4562597830 MENQUADFI VIAL 0.5ML. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies to be delivered by October 26, 2023. No set-aside designation was applied to this order, which was issued against an existing indefinite-delivery contract between Amerisourcebergen and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $1,404.96 contract is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product, with a completion date of February 1, 2024. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of MENQUADFI VIAL 0.5ML pharmaceuticals. The $116,894.72 firm fixed price delivery order was awarded on September 26, 2022 with a completion date of September 27, 2022. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical products. The award, valued at $7,024.80, is a firm-fixed price delivery order that has an ultimate completion date of August 19, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor, and there is no indication of any subcontractors. This delivery order is likely part of a...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB24FK9NUDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4563276138 MENQUADFI VIAL 0.5ML. The potential value of the contract is $1,404.96. This delivery order was issued under Amerisourcebergen's existing contract to provide pharmaceuticals, medical supplies, and related distribution services to DLA Troop Support Medical facilities. Amerisourcebergen has a history of supporting DLA programs by delivering a range of pharmaceutical products and medical materials. No set-aside designation was used for this award, which will be performed at Amerisourcebergen's corporate headquarters in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is also an established prime contractor for the Department of Justice Federal Bureau of Investigation, providing medical supplies and prescription medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/9/24 |